Source: Annual Congress 2006 - Clinical problems: miscellaneous II
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Komus, K. C. Tertemiz, A. Akkoclu (Izmir, Turkey). Pseudomonas aeruginosa colonisation in bronchiectatic patients and clinical reflections. Eur Respir J 2006; 28: Suppl. 50, 458

Member's Comments

No comment yet.

Related content which might interest you: Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?> Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017 The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Source: Eur Respir J 2006; 28: 974-979 Year: 2006 Eradication of Pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2006; 27: 653 Year: 2006 The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017 Year: 2018 Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis Source: Eur Respir J 2004; 24 : 631-637 Year: 2004 Pseudomonas aeruginosa and legionella pneumophilia in water of dental units Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients? Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques Year: 2018 The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018 Year: 2019 Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003